-

Owens & Minor Launches Life Takes Care™

-Life Takes Care reflects Owens & Minor’s unique purpose and critical role in healthcare-

-New purpose and strategic vision shared publicly for the first time on December 6-

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) has unveiled its new purpose, Life Takes Care. More than a motto or tagline, Life Takes Care captures the company’s unique approach to caring for both the business and the humanity at the heart of healthcare.

“Owens & Minor has always been driven by a strong sense of the importance of the work we do behind the scenes for the patients, providers and communities we serve,” said Edward A. Pesicka, President & Chief Executive Officer, Owens & Minor. “Defining that sense of purpose in the statement Life Takes Care allows us to better harness the unstoppable collective strength, creativity and compassion of our teammates as we continue to move our business forward.”

The past few years have brought about historic shifts affecting not only Owens & Minor, but also the healthcare industry as a whole, accelerating trends in where, when and how care is delivered. Research shows that purpose-driven companies experience approximately 14% greater revenue growth, are nearly two times as likely to have above average returns, and have +8% reduced turnover; have +12% fewer safety incidents; and +4% increased profitability. Additionally, a study of high-growth companies found company purpose to be one of four key growth drivers.

Life Takes Care was uncovered and developed using teammate perspectives as well as strategic insights from company leadership. This statement of purpose encompasses the entirety of Owens & Minor’s global business: the Products & Healthcare Services and Patient Direct business segments as well as its affiliated brands, Apria®, Byram® and HALYARD*. Life Takes Care was first unveiled on December 6, 2023 and will be celebrated throughout its inaugural year in 2024.

To learn more about Life Takes Care and Owens & Minor’s vital role in healthcare, visit www.owens-minor.com/about.

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home.

For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram® and HALYARD*, have helped to make each day better for the patients, providers, and communities we serve.

Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™.

For more information about Owens & Minor and our affiliated brands, visit owens-minor.com or follow us on LinkedIn and Instagram.

*Registered Trademark or Trademark of O&M Halyard or its affiliates.

OMI-CORP

OMI-IR

Contacts

Owens & Minor, Inc.

NYSE:ACH
Details
Headquarters: Richmond, VA
CEO: Edward Pesicka
Employees: 6000
Organization: PUB

Release Summary
Owens & Minor announces the launch of Life Takes Care™, formally recognizing the company’s longtime purpose and critical role in healthcare.
Release Versions

Contacts

Social Media Profiles
More News From Owens & Minor, Inc.

Accendra Health Receives Delisting Notice From the New York Stock Exchange

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it received notification from the New York Stock Exchange (“NYSE”) on November 16, 2026, informing it that trading of the Company’s common stock on the NYSE was suspended, effective immediately, and that the NYSE has determined to commence proceedings to delist the Company’s common stock. The NYSE reached its decision to delist the Company’s common stock pursuant to Rule 802.01D of the NYSE Li...

Accendra Health Reports Third Quarter 2026 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today reported financial results for the third quarter ended September 30, 2026. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. “Over the several weeks since I started, a number of themes have become clear to me. We have strong brands, favorable end markets, and a teammate popula...

Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it executed an amendment to its Receivables Purchase Agreement (the “Receivables Sale Program”) on October 29, 2026. The amendment, among other things, extends the Scheduled Termination Date of the facility to October 2029, and the $150 million size of the Receivables Sale Program is unchanged. “We are pleased to have worked with our banking partner to extend the Receivables Sale Program until...
Back to Newsroom